Chicago Equity Partners »

Halozyme Therapeutics shares owned by Chicago Equity Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Chicago Equity Partners from 13F filings

Historical chart of Chicago Equity Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Chicago Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Chicago Equity Partners

Quarter filed Position value Share count Share price at filing
2020-03-31 $1.8M 98k 17.99
2019-12-31 $1.0M 57k 17.73
2019-09-30 $489k 32k 15.52
2019-06-30 $541k 32k 17.17
2019-03-31 $507k 32k 16.09
2018-12-31 $1.2M 79k 14.63
2018-09-30 $1.1M 63k 18.16
2018-06-30 $1.2M 73k 16.87
2018-03-31 $4.6M 235k 19.59
2017-12-31 $4.6M 228k 20.26
2017-09-30 $3.5M 204k 17.37
2017-06-30 $4.0M 315k 12.82
2017-03-31 $2.2M 170k 12.96
2016-12-31 $1.7M 167k 9.88
2016-09-30 $1.0M 84k 12.08
2014-03-31 $160k 13k 12.67
2013-12-31 $197k 13k 14.98